Annual Accounts Receivable
$10.37 M
+$9.82 M+1794.08%
31 December 2023
Summary:
Capricor Therapeutics annual accounts receivable is currently $10.37 million, with the most recent change of +$9.82 million (+1794.08%) on 31 December 2023. During the last 3 years, it has risen by +$9.98 million (+2547.94%). CAPR annual accounts receivable is now at all-time high.CAPR Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$409.70 K
+$39.70 K+10.73%
30 September 2024
Summary:
Capricor Therapeutics quarterly accounts receivable is currently $409.70 thousand, with the most recent change of +$39.70 thousand (+10.73%) on 30 September 2024. Over the past year, it has dropped by -$9.96 million (-96.05%). CAPR quarterly accounts receivable is now -96.05% below its all-time high of $10.37 million, reached on 31 December 2023.CAPR Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CAPR Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -96.0% |
| 3 y3 years | +2547.9% | +4.6% |
| 5 y5 years | - | - |
CAPR Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +2547.9% | -96.0% | +14.8% |
| 5 y | 5 years | at high | -96.0% | ||
| alltime | all time | at high | -96.0% |
Capricor Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $409.70 K(+10.7%) |
| June 2024 | - | $370.00 K(+0.3%) |
| Mar 2024 | - | $369.00 K(-96.4%) |
| Dec 2023 | $10.37 M(+1794.1%) | $10.37 M(+1794.1%) |
| Sept 2023 | - | $547.60 K(0.0%) |
| June 2023 | - | $547.60 K(0.0%) |
| Mar 2023 | - | $547.60 K(0.0%) |
| Dec 2022 | $547.60 K | $547.60 K(0.0%) |
| Sept 2022 | - | $547.60 K(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $547.60 K(+53.4%) |
| Mar 2022 | - | $357.00 K(-8.9%) |
| Dec 2021 | $391.70 K(>+9900.0%) | $391.70 K(+117.4%) |
| Sept 2021 | - | $180.20 K(>+9900.0%) |
| Dec 2020 | $0.00(-100.0%) | $0.00(-100.0%) |
| June 2002 | - | $100.00(0.0%) |
| Mar 2002 | - | $100.00(0.0%) |
| Dec 2001 | $100.00(-90.0%) | $100.00 |
| Dec 2000 | $1000.00(>+9900.0%) | - |
| Dec 1999 | $0.00 | - |
FAQ
- What is Capricor Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Capricor Therapeutics?
- What is Capricor Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Capricor Therapeutics?
- What is Capricor Therapeutics quarterly accounts receivable year-on-year change?
What is Capricor Therapeutics annual accounts receivable?
The current annual accounts receivable of CAPR is $10.37 M
What is the all time high annual accounts receivable for Capricor Therapeutics?
Capricor Therapeutics all-time high annual accounts receivable is $10.37 M
What is Capricor Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of CAPR is $409.70 K
What is the all time high quarterly accounts receivable for Capricor Therapeutics?
Capricor Therapeutics all-time high quarterly accounts receivable is $10.37 M
What is Capricor Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, CAPR quarterly accounts receivable has changed by -$9.96 M (-96.05%)